Tel: 021 601 3365 / Fax: 021 2021030
eMail: cork.rheumatology@materprivate.ie

Aclasta (Zoledronic Acid)

Aclasta (Reclast; Zoledronate) is a bisphosphonate medicine used to treat and prevent thinning of the bones (osteoporosis) and to treat a condition called Paget’s disease.

Taking Aclasta

Aclasta is given once a year by an intravenous (IV) infusion. Infusions take about 15 minutes and must be done at a specialized clinic by a nurse or doctor.

Its important to take calcium & vitamin D while taking Aclasta to help build the bones. Doctors who prescribe Aclasta will advise their patients on the right amount of calcium and vitamin D to take.

Important Tests and Risks

People taking Aclasta should undergo Bone Mineral Density (BMD) tests so their doctor can monitor their body’s response to the medication. This test is usually done once every 1 to 3 years.

Biphosphonate medicines like Aclasta have been associated with a very rare problem with the jaw called osteonecrosis. This problem is sometimes seen after dental work. Patients should let their doctor know if they develop sudden pain in the jaw.

Alcohol is known to increase fracture risk by decreasing bone mineral density and promoting osteoporosis. People who are prescribed Aclasta should stop drinking alcohol, or at least reduce the amount of alcohol that they drink.